European Union: COVID-19 vaccine has ‘clear association’ with brain blood clots

We still do not know what causes this reaction’

Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics. (U.S. Army photo by Jason W. Edwards)

Germany, France, Italy, Spain and other nations have suspended the use of AstraZeneca’s COVID-19 vaccine over concerns it is linked to blood clots.

The manufacturer denies any link, but an official with with the European Union’s agency in charge of evaluating medicines believes there is a “clear association” between the two.

Reuters reported Marco Cavaleri, the chairman of the the European Medicines Agency team evaluating the vaccine, said that in his opinion, “we can now say it, it is clear that there is an association (of the brain blood clots) with the vaccine.”

“However, we still do not know what causes this reaction,” he told the Italian daily Il Messagero.

A spokesman for AstraZeneca declined comment to Reuters, and the EMA later issued a statement saying its review was continuing.

Reuters reported the EMA “has repeatedly said the benefits of the AstraZeneca shot outweigh the risks as it investigates 44 reports of an extremely rare brain clotting ailment known as cerebral venous sinus thrombosis (CVST) out of 9.2 million people in the European Economic Area who have received the vaccine.”

AstraZeneca, one of multiple companies that developed a COVID-19 vaccine over the last year, said it has found no higher risk of clots than normal from its product.

“Cavaleri said the EMA would say in its review that there is a link but was not likely to give an indication this week regarding the age of individuals to whom the AstraZeneca shot should be given,” the report said.

Is there a clear association between COVID vaccines and brain blood clots?

The report said a high proportion among the reported cases involved young and middle-aged women.

European investigators have speculated that the vaccine triggers an unusual antibody in some rare cases. Another speculation was that some cases are linked with birth control pills.

It’s not the first suggestion of  a link, the report said.

“In a separate interview, Armando Genazzani, a member of the EMA’s Committee for Medicinal Products for Human Use (CHMP), told La Stampa daily that it was ‘plausible’ that the blood clots were correlated with the AstraZeneca vaccine.”

The Western Journal noted that officials in the Netherlands say they found blood clots in women between the ages of 25 and 65. And in Germany, nine of 31 patients who had developed CVST died, and 29 cases were found in women between the ages of 20 and 63.

The report said Norway “reported three deaths among people who developed blood clots and hemorrhaging after receiving the vaccine.”

WND previously reported 54,571 adverse events have been reported in Europe in association with the AstraZeneca vaccine, including 198 deaths.

The concerns were raised initially when Denmark suspended use of the vaccine, followed by Ireland, Thailand, the Netherlands, Norway, Iceland, Congo and Bulgaria.


The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.

Be the first to comment

Leave a Reply

Your email address will not be published.